Journal for immunotherapy of cancer.

ISSN 2051-1426BMJ Publishing GroupUnited Kingdom
ScopusMEDLINEEmbasePubMedPMCSCImagoDOAJMatched via identifier

Journal overview

Journal identity
Titles
Journal for ImmunoTherapy of Cancer
J. Immunother. Cancer (abbreviated)
Journal for Immunotherapy of Cancer
J Immunother Cancer (abbreviated)
Journal for immunotherapy of cancer.
Key identifiers
ISSN
Not available
eISSN
2051-1426
NLM ID
101620585
Publisher / basic metadata
Publisher
BMJ Publishing Group
London : BioMed Central, 2013-
Country
Language
ENG
English

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2013–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCCoverage available

Metrics

JIF
Not available
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
4.114
Best Quartile
Q1
H-index
155
Subject categories
  • Cancer Research — Q1
  • Immunology — Q1
  • Immunology and Allergy — Q1
  • Molecular Medicine — Q1
  • Oncology — Q1
  • Pharmacology — Q1
More metrics
Coverage
2013–2026
Country
United Kingdom
Region
Western Europe
Publisher
BMJ Publishing Group
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
688
Total documents (3 years)
1437
Total references
30301
Total citations (3 years)
14995
Citable documents (3 years)
1406
Citations per document (2 years)
9.58
References per document
44.04
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2051-1426
SCImago Source ID
21100466864
SCImago Rank (across all SCImago source types)
415

Publication activity

Publication activity
SCImago
2025
688 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Open access

DOAJ — Directory of Open Access Journals

Source: DOAJ (Directory of Open Access Journals). Listing status and policy details are reported here as DOAJ published them.

Listed in DOAJ
Yes
License
CC BY, CC BY-NC, CC BY-NC-ND
APC (article processing charge)
2390 GBP
More information
Waiver policy
Yes
Review process
Anonymous peer review
Plagiarism screening
Yes
Preservation services
Portico, LOCKSS
Added to DOAJ
2013-09-23
Journal homepage
DOAJ profile
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2051-1426

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Immunotherapy; Neoplasms/immunology*Neoplasms/therapy
Coverage / history
Scopus:2013-2026
MEDLINE:MEDLINE: v4, 2016-In: PubMed: v1, 2013-, PMC;
PubMed:MEDLINE: v4, 2016-In: PubMed: v1, 2013-, PMC;
PMC:v.1 2013 – v.14(9) 2026